Oramed Pharmaceuticals
ORMP
#9214
Rank
A$0.24 B
Marketcap
A$5.91
Share price
1.96%
Change (1 day)
63.56%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): A$95.26 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of A$88.45 Million, an increase over its 2024 earnings that were of -A$21.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$95.26 M7.7%
2025 A$88.45 M-513.21%
2024 -A$21.41 Million-311.47%
2023 A$10.12 M-119.45%
2022 -A$52.05 Million39.17%
2021 -A$37.4 Million73.93%
2020 -A$21.5 Million18.53%
2019 -A$18.14 Million-16.62%
2018 -A$21.76 Million38.32%
2017 -A$15.73 Million12.51%
2016 -A$13.98 Million25.01%
2015 -A$11.19 Million18.18%
2014 -A$9.47 Million39.72%
2013 -A$6.78 Million46.4%
2012 -A$4.63 Million128.32%
2011 -A$2.03 Million-51.47%
2010 -A$4.18 Million35.21%
2009 -A$3.09 Million
2007 -A$4.86 Million607.04%
2006 -A$0.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
A$32.99 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$10.17 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.72 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$86.84 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$49.56 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel